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ABSTRACT: Protein macrocyclization represents a very
efficient strategy to increase the stability of protein tertiary
structures. Here, we describe a panel of novel C3-symmetric
tris-electrophilic agents and their use for the cyclization of
proteins. These electrophiles are reacted with a protein
domain harboring three solvent-exposed cysteine residues,
resulting in the in situ cyclization of the protein (INCYPRO).
We observe a clear dependency of cross-linking rates on the
electrophilicity. All nine obtained cross-linked protein versions
show considerably increased thermal stability (up to 29 °C
increased melting temperature) when compared to that of the
linear precursor. Most interestingly, the degree of stabilization
correlates with the hydrophilicity of the cross-link. These
results will support the development of novel cross-linked proteins and enable a more rational design process.
■ INTRODUCTION
Proteins play a central role in biological processes, and their
unique biocatalytic and recognition properties render them
attractive for many applications, ranging from medical
diagnostics to the synthesis of complex molecular scaffolds.1,2
Protein function is tightly linked to its three-dimensional
structure, which is defined by the primary amino acid sequence
and mediated by intramolecular interactions involving both
backbone and side-chain atoms. This triggers the formation of
secondary structures and allows their assembly into tertiary
structures.3 The use of proteins in biochemical applications can
be hampered by the often required harsh conditions, such as
increased temperature, leading to loss of protein tertiary
structure and therefore functionality. Various approaches have
been developed that facilitate the stabilization of protein
tertiary structures involving sequence variation through
consensus-based mutagenesis, directed evolution, computa-
tional approaches, and/or the introduction of nonproteino-
genic amino acids.4−8 Notably, macrocyclization strategies also
proved effective in stabilizing protein folds as the resulting
covalent intradomain cross-links impede the opening of the
tertiary structure.9−15
A large repertoire of macrocyclization reactions is available
for peptides and small proteins that are accessible via total
chemical synthesis, allowing the incorporation of a variety of
functional groups.16,17 For proteins that are obtained via
heterologous expression, only a limited set of macrocyclization
reactions has been reported, including the introduction of
disulfides,18 disulfide mimics,9 or lactam formation.10−12 To
circumvent the structural prerequisites associated with these
approaches, electrophilic non-natural amino acids have been
introduced into proteins to react with the thiol group of an
appropriately aligned cysteine residue.13,14 We recently
reported a novel approach involving the in situ cyclization of
proteins (INCYPRO, Figure 1a), where we aimed to maximize
the stabilization effect from cross-linking while circumventing
the complications associated with protein expression using
non-natural amino acids.19 INCYPRO involves the introduc-
tion of three spatially aligned cysteines that are located in
different secondary structure elements of the protein. The
three cysteine thiol groups are then reacted with a C3-
symmetric, tris-electrophilic agent composed of a central core
structure (X) that projects three electrophilic groups (El,
Figure 1a). When starting from a linear protein precursor, the
reaction provides a protein with bicyclic topology. At ambient
temperatures, cross-link introduction did not alter the protein
function. Importantly, cross-linking conveyed increased
stability toward thermal and chemical stress.19 So far, only
chloroacetamide-modified tertiary amine core structures were
employed, and it is unclear how variation of the tris-
electrophile affects modification efficiencies and protein
stability.
Herein, we report the synthesis and characterization of
structurally diverse tris-electrophiles suitable for cross-linking
native proteins. We further investigate how derivatization
effects cross-linking reactivity and the stability of the resulting
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Figure 1. (a) Concept of the in situ cyclization of proteins (INCYPRO) using triple cysteine variant of the KIX domain, K1 (aa 586−671, H594C,
L599C, R646C). Reaction occurs between the three introduced thiol groups in K1 and a C3-symmetric core structure (X) decorated with three
electrophilic groups (El). (b) Used electrophilic groups (El, 1, 2, and 3) and the resulting cross-linked products after reaction with a protein-
exposed thiol. (c) C3-symmetric core structures Ae, Ta, and Bz. (d) Lipophilicity (miLogP)20 and flexibility (Nrot. bond: number of rotatable bonds
between two thiol groups) were calculated (for details, see Scheme 1) and plotted.
Scheme 1. Overview of the Nine Cross-Link Structures That Result from the Reaction of the Tris-Electrophiles with Three
Thiol Groupsa
aThe number of rotatable bonds (Nrot. bonds) was determined for the shortest chain between two thioether moieties (R = S-protein). Rotatable
bonds are highlighted in red. For calculation of miLogP values, structures were considered as depicted (R = H). For calculations, Molinspiration was
used.20
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bicyclic protein. In total, nine structurally distinct cross-links
were designed and their corresponding tris-electrophiles
synthesized. Subsequently, their reaction with the KIX protein
domain containing three appropriately positioned cysteines
(K1) was investigated.
■ RESULTS AND DISCUSSION
Design of Tris-Electrophilic Agents. We selected
acrylamide (1), chloroacetamide (2), and vinyl sulfonamide
(3, Figure 1b) as reactive groups to utilize their distinct
electrophilicities (1 < 2 < 3).21,22 In addition, three different
core structures, based on triethylamine (Ae), triazinane (Ta),
and benzene (Bz),23 were chosen. These structures possess a
C3-symmetric geometry and bear three amino groups to
enable the functionalization with the electrophiles (Figure 1c).
The combination of the three electrophiles (1−3) with the
three core structures (Ae, Ta, Bz) results in nine different tris-
electrophilic reagents (Figure S1), which upon cross-linking
with the three cysteines in protein K1 results in nine
structurally diverse cross-links (indicated by *, Scheme 1).
We expected these cross-links to exhibit distinct physicochem-
ical properties and decided to focus on flexibility and
hydrophobicity as two very important characteristics.24 Based
on a classification usually applied for the characterization of
bioactive small molecules, we used the number of rotatable
bonds (Nrot. bonds) as a measure for flexibility. Here, we
considered the shortest chain between two of the thioether
moieties (red = rotatable bond, Scheme 1) using the isolated
cross-link as a basis. Overall, the number of rotatable bonds
ranges from eight (*Ta2 and *Bz2) to 14 (*Ae3). To estimate
cross-link lipophilicity, we calculated miLogP values, which
show a broad distribution for our set of cross-links ranging
from rather hydrophobic (*Bz1: miLogP = 1.14) to relatively
polar structures (*Ae2: miLogP = −4.87, Scheme 1). In these
calculations, the triethylamine core (Ae) was presumed to be
protonated as we were interested in these properties at neutral
pH (R3NH
+, ca. pKa 9). When plotting Nrot. bond against
miLogP values for all cross-links (Figure 1d), we observe a
relatively broad and even distribution of both characteristics
within our cross-link library. Notably, both the core structure
and the reacted electrophilic moiety add to the overall cross-
link diversity.
Amidation Reactions of Triamine Cores. For the
assembly of the desired tris-electrophilic molecules, we aimed
for tris-amino-functionalized cores (4−6) as precursors that
could be functionalized via (sulfon)amide formation (Scheme
2). The tris-amino version of the Ae core (4) is commercially
available, whereas the corresponding derivative of Bz (6) is
readily accessible following literature procedures.25,26 The tris-
amino derivative of the Ta core (5) was synthesized in good
yields, starting from tribromide 727 via an azide substitution
reaction yielding triazide 8 and a subsequent catalytic
hydrogenation in 82 and 70% yield, respectively. With tris-
amino-functionalized cores 4−6 in hand, we proceeded with
the coupling of electrophilic moieties (1−3) using acid
chlorides 9 and 10 and sulfonyl chloride 11. Such reactions
have been reported to typically result in low yields due to both
competing polymerization reactions between unreacted amine
and the attached electrophile and intramolecular reactions.28,29
For the synthesis of acrylamide-modified cores (Ae1, Ta1,
Bz1), tris-amino-functionalized molecules 4−6 were reacted
with acryloyl chloride (9) using an excess of inorganic base in a
mixture of water and organic solvent. For Bz1, the yields were
relatively low (10%) when compared to those of Ae1 (44%)
and Ta1 (24%), mainly due to the poor solubility. Using a
similar procedure, tris-chloroacetamides (Ae2, Ta2, Bz2) were
synthesized in yields ranging from 18 to 41%. For the synthesis
of vinyl sulfonamides (Ae3, Ta3, Bz3), a different protocol was
applied (i.e., Et3N, DCM, −60 °C to rt)21 using 2-
chloroethanesulfonyl chloride (11). In these cases, yields
were generally low due to more pronounced polymerization
reactions caused by the high electrophilicity of the vinyl
sulfonamides. All tris-electrophilic agents were isolated in good
purity and sufficient quantities for in situ cyclization with K1.
In Situ Cyclization of Protein K1. The triple-cysteine
variant of the KIX domain, K1 (aa 586−671, H594C, L599C,
R646C) previously applied to establish the INCYPRO
approach, was used as a model protein. Initially, the reactions
between K1 and the three tris-electrophilic Ae cores (Ae1,
Ae2, Ae3) were performed at pH 8.5 following the original
protocol.19 High-performance liquid chromatography in
combination with mass spectrometry (HPLC−MS) clearly
indicated the formation of the cross-linked proteins (Figure
2a) and verified the expected reactivity trend (Ae1 < Ae2 <
Ae3). Adjusted reaction conditions (Table S1) facilitated
quantitative conversion in all three cases, as confirmed by
HPLC−MS (Figure 2b). Encouraged by these results, we
reacted all tris-electrophiles with K1 at three different pH
values (8.5, 7.5, 6.5) taking samples after 1, 3, and 5 h (Figures
S2−S4). The heat map representation of these measurements
(Figure 2c) reveals similar reactivity trends for all three cores,
showing slower conversion with reduced electrophilicity (3 > 2
> 1). Not surprisingly, overall reactivity decreases with
decreasing pH owing to a reduced nucleophilicity of the
thiol groups. Nevertheless, for all vinyl sulfonamide (3)-based
tris-electrophiles, we observed considerable product formation
even at pH 6.5. Under individually optimized reaction
conditions (Table S1), we were able to obtain full conversion
Scheme 2. (a) Synthesis of Tris-Amino-Functionalized Core
Ta (5) and (b) Synthesis of Tris-Electrophilic Agents Ae1−
3, Ta1−3, and Bz1−3 Starting from Their Tris-Amino
Precursors (4−6)
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for all tris-electrophiles (Figures S5−S13). Importantly, we did
not observe any protein multimerization, which indicates that
the first nucleophilic attack is the rate-limiting step and is in
agreement with our previous study.19 For chloroacetamide-
based electrophiles Ae2, Ta2, and Bz2, loss of the three Cl
atoms verifies the reaction with all three cysteines in K1. In
these cases, we did not observe any partially reacted tris-
electrophiles, indicating that after a first reaction, the
subsequent two intramolecular reactions proceed rapidly,
presumably due to increased effective concentrations. We
expect an analogous behavior for acrylamide- and vinyl-
sulfonamide-based electrophiles, but our MS data are not
suitable for verification because intramolecular addition
reactions do not change the overall molecular weight. To
probe for free cysteines, K1, K1-Bz1, and K1-Bz3 were
incubated with an excess of iodoacetamide, which selectively
alkylates free thiols. As expected, K1 was quantitatively
converted into the tris-alkylated product (Figure S16).
Importantly, we do not observe any alkylation for K1-Bz1
and K1-Bz3, indicating the absence of unreacted cysteines
(Figure S16).
Thermal Stability of Cross-Linked K1. The KIX domain
has been structurally characterized, revealing three central α-
helices as the core secondary structure elements (Figure 1a).30
To assess the structural properties of our cross-linked variants,
we performed circular dichroism (CD) spectroscopy. As
expected, the CD spectrum of K1 shows the two minima
around λ = 210 and 222 nm (Figure 3a), indicative of the
presence of α-helices. Based on the signal at 222 nm, a helical
content of 39% was determined that lies in the expected
range.30,31 We then measured the CD spectra of all cross-
linked K1 derivatives showing analogous characteristics
(Figure 3a and Figures S17 and S18). Consequently, all
cross-linked K1 versions exhibit similar helicities ranging from
34 to 44%. This indicates that the different cross-links do not
impact the overall structure of K1. Subsequently, we measured
the temperature dependence of the CD signal at λ = 222 nm,
providing melting curves (Figure 3c and Figures S19 and S20)
that allow the determination of the melting temperatures (Tm).
For all cross-linked K1 derivatives, we observe a melting
temperature higher than that for the linear precursor K1
(Figure 3d). Differences in Tm values range from 19 °C for K1-
Figure 2. (a) HPLC chromatograms of reactions between K1 and
Ae1, Ae2, and Ae3 (pH 8.5, 25 °C, after 1 and 5 h). (b) Electrospray
ionization (ESI) mass spectra of cross-linked K1. (c) Heat map
representation of reaction yield, allowing a comparison of relative
reaction rates (analytical yields are based on HPLC chromatograms,
Figures S2−S4).
Figure 3. (a) CD spectra of K1, and cross-linked K1-Ae1, K1-Ae2,
and K1-Ae3 are shown in molar ellipticity [θ]. (b) Overview of
calculated helicities based on the CD signal at λ = 222 nm (for spectra
of Ta- and Bz-cross-linked K1, see Figures S17 and S18). (c) Thermal
denaturation curves of K1 and cross-linked K1-Ae1, K1-Ae2, and K1-
Ae3. The CD signal was recorded at λ = 222 nm as a function of
temperature. (d) Overview of Tm values derived from the
corresponding thermal denaturation curves (Figures S19 and S20).
(e) Number of rotatable bonds between two thioether groups
(Nrot. bonds) vs melting temperatures (Tm), including the resulting
Pearson correlation coefficient (ρ). (f) Calculated miLogP values vs
melting temperatures (Tm), including the resulting Pearson
correlation coefficient (ρ).
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Bz1 (Tm = 78 °C) to 29 °C for K1-Ae2 (Tm = 88 °C) when
compared to that of K1 (Tm = 59 °C), indicating that
individual cross-links result in a different degree of thermal
stabilization.
Having initially calculated parameters indicative of cross-link
flexibility and hydrophobicity (Figure 1d and Scheme 1), we
were interested if there is any correlation of these parameters
with the thermal stability of the cross-linked proteins.
Therefore, we plotted the number of rotatable cross-link
bonds between two of the formed thioethers (Nrot. bond,
Scheme 1) against the determined Tm values and determined
a Pearson correlation coefficient of ρ = 0 (Figure 3e). Values of
ρ can range between −1 and 1, with the value 0 indicating the
absence of any correlation. The lack of correlation between
thermal stability (Tm) and flexibly (Nrot bonds) in our data set is
also highlighted by the fact that the most stable protein K1-
Ae2 (Tm = 88 °C) and the cross-linked protein with the lowest
stability K1-Bz1 (Tm = 78 °C) possess the same number of
rotatable cross-link bonds (Nrot bonds = 10). On the other hand,
a plot of Tm values against calculated miLogP, which is a
measure for lipophilicity, shows a clear correlation of ρ =
−0.87 (Figure 3f). Here, the most lipophilic cross-link, *Bz1
(miLogP = 1.14), can be found in the least stable cross-linked
protein, K1-Bz1 (Tm = 78 °C), whereas the most stable
protein, K1-Ae1 (Tm = 88 °C), harbors the most hydrophilic
cross-link, *Ae1 (miLogP = −4.87). In general, we observe a
lower degree of stabilization for the most hydrophobic
benzene-derived core Bz, whereas both relatively polar core
structures Ae and Ta contribute more to stability. In addition,
it is interesting to note that the most hydrophilic thioether
moiety originating from the reaction of chloroacetamide (2) is
for each core the most stable derivative (Ae2, Bz2, and Ta2,
for the latter together with Ta3).
■ CONCLUSIONS
We report the synthesis of a panel of nine tris-electrophiles
(Figure S1) originating from a combination of three core
structures (Ae, Ta, and Bz) and three electrophilic moieties
(1−3). Among these tris-electrophiles, only Ae2 has been
previously reported.19 The final step in the synthesis of
reagents containing acrylamide (1) and chloroacetamide (2)
involved amide bond formation between tris-amino cores (4−
6) and acid chloride derivatives (9 and 10, Scheme 2). For
vinyl sulfonamide (3)-containing products, the tris-amino
cores (4−6) were reacted with 2-chloroethanesulfonyl chloride
(11). As previously reported, these (sulfone)amide formations
proceeded with only low to moderate yields, mainly owing to
undesired inter- and intramolecular reaction of unreacted
amines with already coupled electrophilic groups.28,29 For this
reason, the most reactive vinyl-sulfonamide-modified cores
(Ae3, Ta3, and Bz3) were obtained with lowest yields (2−
10%).
All tris-electrophiles were obtained in good purities suitable
for the cross-linking of protein K1. Protein K1 comprises 88
amino acids and possesses three cysteine residues appropriately
aligned for the reaction with our tris-electrophilic agents. The
reaction between K1 and Ae2 yields bicyclic protein K1-Ae2
and had been previously described by us.19 In addition to
chloroacetamide (2), we selected acrylamide (1) and vinyl
sulfonamide (3) which, in aqueous solution, are more and less
electrophilic, respectively. The cross-linking reactions were
performed in buffered solution at three different pH values
(6.5, 7.5, and 8.5, T = 25 °C). At pH 8.5, we observed product
formation for all tris-electrophiles including the least reactive
ones bearing the acrylamide (1, Figure 2C). As expected,
conversion to cross-linked K1 becomes slower with decreasing
pH values. Most notably, even at pH 6.5 and only 5 h reaction
time, we observed more than 50% product formation for all
vinyl sulfonamide (3)-containing cores (Ae3, Ta3, Bz, Figures
S2−S4). This is a remarkable finding as it broadens the
applicability of the INCYPRO approach to proteins that are
either not stable or soluble at higher pH values.
Using individually optimized reaction conditions (Table S1),
we obtained all cross-linked K1 versions as confirmed by MS
(Figures S5−S13). CD spectroscopy indicates a similar helical
content for all cross-linked proteins (34−44%), which was in
the range of the linear precursor K1 (39%, Figure 3b),
suggesting that cross-linking does not interfere with the overall
protein structure. When determining the thermal stability using
CD melting experiments, all cross-linked K1 proteins showed
considerably increased melting temperatures (Tm = 78−88 °C)
when compared to linear K1 (Tm = 59 °C, Figure 3d). A clear
dependency between thermal stabilization of the modified
protein and lipophilicity of the introduced cross-link can be
observed and results in a very good correlation coefficient (Tm
vs miLogP: ρ = −0.87). This indicates that protein stability
particularly benefits from cross-links with hydrophilic
structures, which is supported by findings from protein surface
engineering showing that increasing the overall polarity of the
protein surface increases protein stability, presumably due to a
reduced tendency for aggregation.7 The opposite is the case for
the introduction of hydrophobic solvent-exposed residues.
However, it remains to be seen if the stability trends observed
for K1 are also generally applicable for other proteins.
Taken together, we report novel tris-electrophilic molecules
suitable for protein cross-linking using the in situ cyclization of
proteins (INCYPRO) approach. These molecules vary in their
electrophilicity, thereby broadening the accessible pH range,
for example, potentially enabling the cross-linking of proteins
that are not stable under basic conditions. Most notably, all
nine cross-linked versions of K1 showed considerably
increased thermal stability (ΔTm ≥ 19 °C), and it appears
that the degree of stabilization is more pronounced when
hydrophilic cross-links are attached. These findings will
support the future development of cross-linked proteins and
enable a more rational design process.
■ EXPERIMENTAL SECTION
General Methods. Unless stated otherwise, all solvents and
commercially available reagents were used as purchased. Benzene-
1,3,5-triyltrimethanamine (6) and 1,1′,1″-(1,3,5-triazinane-1,3,5-
triyl)tris(2-bromoethan-1-one) (7) were synthesized according to
literature procedures.25−27 Unless stated otherwise, all solvents and
commercially available reagents were used as purchased. Nuclear
magnetic resonance (NMR) spectra were recorded on a Bruker
AVANCE 600 MHz (150.92 MHz for 13C), Bruker AVANCE 500
MHz (125.78 MHz for 13C), or Bruker AVANCE 300 MHz (83.85
MHz for 13C) as indicated below. The residual solvent was used as an
internal standard (1H, δ 7.26 ppm; 13C{1H}, δ 77.16 ppm for CDCl3;
1H, δ 2.50 ppm; 13C{1H}, δ 39.52 ppm for DMSO-d6). Chemical
shifts (δ) are given in parts per million (ppm), and coupling constants
(J) are quoted in hertz (Hz). Resonances are described as s (singlet),
d (doublet), t (triplet), q (quartet), quint (quintet), sex (sextet), sep
(septet), br (broad singlet), and m (multiplet) or combinations
thereof. Infrared (IR) spectra were recorded neat using a Shimadzu
FTIR-8400s spectrophotometer, and wavelengths are reported in
cm−1. Electrospray ionization (ESI) high-resolution mass spectrom-
etry (HRMS) was carried out using a Bruker microTOF-Q instrument
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in positive ion mode (capillary potential of 4500 V). Flash
chromatography was performed manually on Silicycle Silia-P flash
silica gel (particle size 40−63 μm, pore diameter 60 Å) using the
indicated eluent. Reversed-phase chromatography was performed
using a Biotage Isolera equipment using Biotage SNAP cartridges or
an Xbridge prep (C18) 5 μm column (19 mm × 100 mm). Thin layer
chromatography (TLC) was performed using TLC plates from Merck
(SiO2, Kieselgel 60 F254 neutral, on aluminum with fluorescence
indicator), and compounds were visualized by UV detection (254
nm) and KMnO4 stain. Mass spectrometry analyses were performed
using a Shimadzu LCMS-2020 mass spectrometer. The data were
acquired in full-scan APCI mode (MS) from m/z 100 to 800 in
positive ionization mode. Data were processed using Shimadzu
Labsolutions 5.82. Protein and cross-linker identity and purity were
confirmed by HPLC/ESI-MS analysis performed in a HPLC-MS
system (Agilent Technologies) provided with a Zorbax Eclipse, XDB-
C18 reverse-phase column (4.6 × 150 mm, particle size 5 μm,
Agilent; solvent A: H2O + 0.1% TFA; solvent B: acetonitrile +0.1%
TFA; flow rate of 1 mL min−1).
1,1′,1″-(1,3,5-Triazinane-1,3,5-triyl)tris(2-azidoethan-1-one) (8).
To a solution of sodium azide (1.25 g, 19.2 mmol, 3.2 equiv) in DMF
(100 mL) was added 1,1′,1″-(1,3,5-triazinane-1,3,5-triyl)tris(2-
bromoethan-1-one) (7, 2.7 g, 6 mmol, 1 equiv), and the solution
was stirred for 40 h at room temperature. After full consumption of
the starting material, water was added and the product was extracted
with EtOAc. The combined organic layers were washed with brine,
dried over Na2SO4, and concentrated in vacuo. The crude mixture
was purified by flash chromatography using EtOAc/cyclohexane (3:1)
as eluent to obtain the product as a white amorphous solid (1.65 g,
4.91 mmol, 82%): Rf = 0.15 (EtOAc/cyclohexane 3:1);
1H NMR
(500 MHz, DMSO-d6) δ 5.16 (s, 6H), 4.27 (s, 6H);
13C NMR (126
MHz, DMSO-d6) δ 167.3 (3C), 55.0 (3C), 49.6 (3C); IR (neat) νmax
(cm−1) = 2104, 1649, 1413, 1236, 947; HRMS-ESI (m/z) [M + H]+
calcd for C9H13N12O3, 337.1228; found, 337.1228.
1,1′,1″-(1,3,5-Triazinane-1,3,5-triyl)tris(2-aminoethan-1-one)
(5). To a solution of 1,1′,1″-(1,3,5-triazinane-1,3,5-triyl)tris(2-
azidoethan-1-one) (8, 1 g, 2.97 mmol, 1.0 equiv) in MeOH (20
mL) and DMF (5 mL) was added Pd/C (10 wt %, 319 mg, 0.3
mmol). Hydrogen gas was added via a balloon under atmospheric
pressure. TLC showed complete conversion of the starting material
after 1 h. The suspension was filtered over Celite and concentrated in
vacuo to obtain the product as a white amorphous solid (530 mg, 2.05
mmol, 70%): 1H NMR (500 MHz, DMSO-d6) δ 5.21 (s, 6H), 3.49 (s,
6H); 13C NMR (126 MHz, DMSO-d6) δ 172.5 (3C), 54.9 (3C), 43.5
(3C); IR (neat) νmax (cm
−1) = 3367, 1647, 1610, 1490, 1200, 845;
HRMS-ESI (m/z) [M + H]+ calcd for C9H19N6O3, 259.1513; found,
259.1526.
General Procedure A. To a solution of triamine 4−6 (1.0 equiv)
in CH2Cl2(1 M) was added K2CO3 (5.0 equiv, 6 M) in H2O at 0 °C.
Upon vigorous stirring, acid chloride (3.3 equiv) was dropwise added,
and the mixture was allowed to stir at room temperature overnight.
The mixture was diluted with water and extracted three times with
CH2Cl2. Subsequently, the organic layer was washed with brine, dried
over Na2SO4, and concentrated in vacuo. The crude was further
purified by silica gel column chromatography.
General Procedure B. To a solution of 2-chloroethanesulfonyl
chloride (3.3 equiv) in CH2Cl2 (1.0 M) was added triethylamine (3.6
equiv) at −60 °C. After being stirred for 2 h, a solution of triamines
4−6 (1.0 equiv) and triethylamine (3.3 equiv) in CH2Cl2 (0.5 M) was
dropwise added, after which the temperature was allowed to slowly
increase to room temperature over 16 h. Next, the suspension was
filtered and quenched in cold HCl (0.1 M). The product was
extracted with CH2Cl2, dried over Na2SO4, and concentrated in
vacuo. The crude was further purified by silica gel column
chromatography.
N,N′,N″-(Nitrilotris(ethane-2,1-diyl))triacrylamide (Ae1). Pre-
pared according to general procedure A using tris(2-aminoethyl)-
amine (4, 1.5 mL, 10 mmol), K2CO3 (6.84 g, 49.5 mmol), and
acryloyl chloride (2.67 mL, 33 mmol). The title compound was
isolated without purification as a white amorphous solid (1.36 g, 4.4
mmol, 44%): 1H NMR (500 MHz, DMSO-d6) δ 8.01 (d, J = 5.6 Hz,
3H), 6.25 (dd, J = 17.1, 10.2 Hz, 3H), 6.07 (dd, J = 17.1, 2.2 Hz, 3H),
5.57 (dd, J = 10.2, 2.2 Hz, 3H), 3.17 (q, J = 6.3 Hz, 6H), 2.53 (t, J =
6.6 Hz, 6H); 13C NMR (126 MHz, DMSO-d6) δ 164.2 (3C), 131.8
(3C), 126.3 (3C), 53.3 (3C), 37.0 (3C); IR (neat) νmax (cm
−1) =
3209, 1650, 1614, 1408, 1240, 1171, 955; HRMS-ESI (m/z) [M +
H]+ calcd for C15H25N4O3, 309.1921; found, 309.1941.
N,N′,N″-(Nitrilotris(ethane-2,1-diyl))tris(2-chloroacetamide)
(Ae2). Prepared according to general procedure A using tris(2-
aminoethyl)amine (4, 1.5 mL, 10 mmol), K2CO3 (6.84 g, 49.5
mmol), and chloroacetyl chloride (2.63 mL, 33 mmol). The title
compound was isolated without purification as a white amorphous
solid (1.55 g, 4.1 mmol, 41%): 1H NMR (600 MHz, DMSO-d6) δ
8.08 (t, J = 5.6 Hz, 3H), 4.06 (s, 6H), 3.14 (q, J = 6.3 Hz, 6H), 2.52
(t, J = 6.7 Hz, 6H); 13C NMR (151 MHz, DMSO-d6) δ 166.1 (3C),
52.9 (3C), 42.7 (3C), 37.4 (3C); IR (neat) νmax (cm
−1) = 3246, 1654,
1545, 1431, 1171; HRMS-ESI (m/z) [M + H]+ calcd for
C12H22Cl3N4O3, 375.0752; found, 375.0765.
N,N′,N″-(Nitrilotris(ethane-2,1-diyl))triethenesulfonamide (Ae3).
Prepared according to general procedure B with a cross-linker by
treating a solution of 2-chloroethanesulfonyl chloride (236 μL, 2.26
mmol) and triethylamine (338 μL, 2.47 mmol) in CH2Cl2 (3 mL)
with a solution of tris(2-aminoethyl)amine (4, 103 μL, 0.69 mmol)
and triethylamine (310 μL, 2.26 mmol) in CH2Cl2 (2 mL). The crude
was purified by C18 reversed-phase column chromatography to
obtain the title compound as a viscous oil (28 mg, 0.067 mmol, 10%):
1H NMR (500 MHz, DMSO-d6) δ 7.10 (t, J = 5.8 Hz, 3H), 6.72 (dd,
J = 16.5, 10.0 Hz, 3H), 6.05 (d, J = 16.5 Hz, 3H), 6.00 (d, J = 9.9 Hz,
3H), 2.87 (q, J = 6.0 Hz, 6H), 2.48 (t, J = 6.1 Hz, 6H); 13C NMR
(126 MHz, DMSO-d6) δ 136.8 (3C), 125.8 (3C), 53.5 (3C), 40.3
(3C); IR (neat) νmax (cm
−1) = 3196, 1651, 1614, 1547, 1240, 955;
HRMS-ESI (m/z) [M + H]+ calcd for C12H25N4O6S3, 417.0931;
found, 417.0949.
N,N′,N″-((1,3,5-Triazinane-1,3,5-triyl)tris(2-oxoethane-2,1-diyl))-
triacrylamide (Ta1). Prepared according to general procedure A
using 1,1′,1″-(1,3,5-triazinane-1,3,5-triyl)tris(2-aminoethan-1-one)
(5, 50 mg, 0.19 mmol), K2CO3 (173 mg, 1.26 mmol, 6.6 equiv),
and acryloyl chloride (51 μL, 0.63 mmol). The crude was purified by
C18 reversed-phase column chromatography to obtain the title
compound as a white amorphous solid (19 mg, 0.045 mmol, 24%):
1H NMR (500 MHz, DMSO-d6) δ 8.33 (s, 3H), 6.33 (dd, J = 17.1,
10.2 Hz, 3H), 6.09 (dd, J = 17.1, 2.1 Hz, 3H), 5.62 (dd, J = 10.2, 2.1
Hz, 3H), 5.30 (s, 6H), 4.23 (d, J = 5.5 Hz, 6H); 13C NMR (126 MHz,
DMSO-d6) δ 168.7 (3C), 164.5 (3C), 132.5 (3C), 125.8 (3C), 57.0
(3C), 40.8 (3C); IR (neat) νmax (cm
−1) = 3275, 1649, 1535, 1408,
1240, 1194, 945; HRMS-ESI (m/z) [M + H]+ calcd for C18H25N6O6,
421.1830; found, 421.1847.
N,N′,N″-((1,3,5-Triazinane-1,3,5-triyl)tris(2-oxoethane-2,1-diyl))-
tris(2-chloroacetamide) (Ta2). Prepared according to general
procedure A using 1,1′,1″-(1,3,5-triazinane-1,3,5-triyl)tris(2-amino-
ethan-1-one) (5, 50 mg, 0.19 mmol), K2CO3 (173 mg, 1.26 mmol, 6.6
equiv), and chloroacetyl chloride (62 μL, 0.63 mmol). The crude was
purified by C18 reversed-phase column chromatography to obtain the
title compound as a white amorphous solid (27 mg, 0.055 mmol,
29%): 1H NMR (600 MHz, DMSO-d6) δ 8.37 (s, 3H), 5.28 (s, 6H),
4.20 (s, 6H), 4.15 (s, 6H); 13C NMR (126 MHz, DMSO) δ 167.7
(3C), 166.2 (3C), 55.2 (3C), 42.4 (3C), 40.8 (3C); IR (neat) νmax
(cm−1) = 3272, 1649, 1626, 1535, 1407, 1240, 1171, 926; HRMS-ESI
(m/z) [M + H]+ calcd for C15H22Cl3N6O6, 487.0661; found,
487.0685.
N,N′,N″-((1,3,5-Triazinane-1,3,5-triyl)tris(2-oxoethane-2,1-diyl))-
triethenesulfonamide (Ta3). Prepared according to a modified
general procedure B by treating a solution of 2-chloroethanesulfonyl
chloride (91 μL, 0.87 mmol) and triethylamine (130 μL, 0.83 mmol)
in MeCN (1 mL) at −30 °C with a solution of 1,1′,1″-(1,3,5-
triazinane-1,3,5-triyl)tris(2-aminoethan-1-one) (5, 59 mg, 0.23
mmol) and triethylamine (103 μL, 0.76 mmol) in DMSO/H2O
(2:1, 1.5 mL). The reaction was stopped by pouring it into cold
MeCN/water (1:1, with 0.1% formic acid). The crude was lyophilized
and thereafter purified by C18 reversed-phase column chromatog-
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raphy to obtain the title compound as a white foamy solid (5 mg, 9.5
μmol, 4%): 1H NMR (600 MHz, DMSO-d6) δ 7.56 (s, 3H), 6.67 (dd,
J = 16.5, 10.0 Hz, 3H), 6.01 (d, J = 16.5 Hz, 3H), 5.90 (d, J = 10.0
Hz, 3H), 5.20 (s, 6H), 4.02 (s, 6H); 13C NMR (151 MHz, DMSO-
d6) δ 166.7 (3C), 137.1 (3C), 127.0 (3C), 55.4 (3C), 43.9 (3C); IR
(neat) νmax (cm
−1) = 3277, 1651, 1533, 1410, 1240, 1195, 943;
HRMS-ESI (m/z) [M + H]+ calcd for C15H25N6O9S3, 529.0840;
found, 529.0862.
N,N′,N″-(Benzene-1,3,5-triyltris(methylene))triacrylamide (Bz1).
To a solution of benzene-1,3,5-triyltrimethanamine (6, 250 mg,
1.51 mmol, 1 equiv) in MeCN (6 mL) and water (4 mL) was added
NaOH (302 mg, 7.55 mmol, 5.0 equiv), and the mixture was cooled
to 0 °C. Then, acryloyl chloride (440 uL, 5.44 mmol, 3.6 equiv) was
added dropwise, and the reaction was allowed to go to room
temperature, and stirring was continued for 4 h. After this time,
MeCN was removed and the resulting mixture was extracted with
EtOAc (twice). The combined organic layers were washed with brine,
dried over Na2SO4, filtered, and concentrated in vacuo. The crude was
purified by C18 reversed-phase column chromatography to obtain,
after freeze-drying (from MeCN/water 1:1 and FA 0.1%), the title
compound, which was isolated as a white amorphous solid (47 mg,
0.13 mmol, 10%): 1H NMR (500 MHz, DMSO-d6) δ 8.62 (t, J = 6.0
Hz, 3H), 7.04 (s, 3H), 6.26 (dd, J = 17.1, 10.1 Hz, 3H), 6.11 (dd, J =
17.1, 2.3 Hz, 3H), 5.61 (dd, J = 10.1, 2.2 Hz, 3H), 4.30 (d, J = 6.0 Hz,
6H); 13C NMR (126 MHz, DMSO-d6) δ 164.5 (3C), 139.6 (3C),
131.7 (3C), 125.5(3C), 125.2 (3C), 42.1 (3C); IR (neat) νmax (cm
−1)
= 3292, 1651, 1535, 1408, 1240, 1196, 945; HRMS-ESI (m/z) [M +
Na]+ calcd for C18H21N3NaO3, 350.1475; found, 350.1465.
N,N′,N″-(Benzene-1,3,5-triyltris(methylene))tris(2-chloroaceta-
mide) (Bz2). Prepared according to general procedure A using
benzene-1,3,5-triyltrimethanamine (6, 330 mg, 2 mmol), K2CO3
(1.24 g, 9 mmol), and chloroacetyl chloride (573 uL, 7.2 mmol).
The title compound was isolated after trituration with EtOAc as a
white amorphous solid (139 mg, 0.35 mmol, 18%): 1H NMR (500
MHz, DMSO-d6) δ 8.75 (t, J = 6.0 Hz, 3H), 7.05 (s, 3H), 4.26 (d, J =
5.9 Hz, 6H), 4.11 (s, 6H); 13C NMR (126 MHz, DMSO-d6) δ 166.0
(3C), 139.2 (3C), 125.0 (3C), 42.7 (3C), 42.4 (3C); IR (neat) νmax
(cm−1) = 3292, 1649, 1535, 1408, 1238, 1196, 943; HRMS-ESI (m/
z) [M + H]+ calcd for C15H19Cl3N3O3, 394.0487; found, 394.0506.
N , N ′ , N ″ - ( B e n z e n e - 1 , 3 , 5 - t r i y l t r i s ( m e t h y l e n e ) ) -
triethenesulfonamide (Bz3). Prepared according to general proce-
dure B by treating a solution of 2-chloroethanesulfonyl chloride (1.25
mL, 11.9 mmol) and triethylamine (1.33 mL, 9.54 mmol) in CH2Cl2
(20 mL) with a solution of benzene-1,3,5-triyltrimethanamine (6,500
mg, 2.65 mmol) and triethylamine (1.21 mL, 8.75 mmol) in CH2Cl2
(10 mL). The crude was purified by flash chromatography using
EtOAc/cyclohexane (2:1) as eluent to obtain the title compound as a
yellowish oil (24 mg, 0.055 mmol, 2.1%): Rf =0.18 (EtOAc/
cyclohexane 2:1); 1H NMR (500 MHz, chloroform-d) δ 7.21 (s, 3H),
6.54 (dd, J = 16.5, 9.9 Hz, 3H), 6.25 (d, J = 16.5 Hz, 3H), 5.99 (d, J =
9.9 Hz, 3H), 5.29 (t, J = 6.6 Hz, 3H), 4.08 (d, J = 6.4 Hz, 6H); 13C
NMR (126 MHz, CDCl3) δ 138.1 (3C), 135.7 (3C), 127.6 (3C),
127.4 (3C), 46.6 (3C); IR (neat) νmax (cm
−1) = 3277, 1643, 1535,
1427, 1317, 1142, 946; HRMS-ESI (m/z) [M + H]+ calcd for
C15H22N3O6S3, 436.0665; found, 436.0693.
Protein Expression and Purification. The expression vector
pGEX-4t-3 carrying the coding sequence was transformed into E. coli
BL21-Gold (DE3). A 2 L TB culture was incubated at 37 °C to OD600
= 1; then protein expression was induced by addition of 0.5 mM
IPTG and performed overnight at 20 °C. Cells were harvested by
centrifugation, resuspended in lysis buffer (50 mM Tris, pH 7.4, 500
mM NaCl, 0.5 mM PMSF, and 2 mM DTT), and disrupted using a
microfluidizer (three rounds). The cell lysate was cleared by
centrifugation (20 000 rpm, 4 °C, 60 min). GST-tagged K1 was
isolated from the supernatant by affinity chromatography (Aekta Pure,
GSTPrep FF 16/10, GE Healthcare, 4 °C). After being loaded, the
column was washed with wash buffer (50 mM Tris, pH 7.4, 100 mM
NaCl, 2 mM DTT) until baseline (OD280) was reached. PreScission
(His-tagged) cleavage was performed on the column overnight at 4
°C in wash buffer. Protein K1 was eluted with wash buffer and
incubated with Ni-NTA agarose resin (10 min, rt). After removal of
the resin by centrifugation, the target protein was concentrated via
ultrafiltration to approximately 9 mg mL−1 (Amicon, Merck, 3 kDa
MWCO, rt). Subsequent size-exclusion chromatography was
performed (Aekta Pure, Column HiLoad 16/600 Superdex 75 pg,
GE Healthcare in 25 mM HEPES, pH 7.4, 100 mM NaCl, 0.5 mM
TCEP). Purified K1 was concentrated (Amicon, Merck, 3 kDa
MWCO, rt) to approximately 2−5 mg mL−1, snap frozen, and stored
at −80 °C. Generated vector constructs were sequence proven by
Sanger sequencing and protein purity confirmed via SDS-PAGE.
Protein Modification with Tris-Electrophiles. For time- and
pH-dependent analysis of product formation, 50 μM K1 was
incubated with 1 mM tris-electrophile (100 mM in DMSO) in
cross-linking buffer (50 mM HEPES, 50 mM NaCl, pH 6.5, 7.5 or
8.5) at 25 °C and 350 rpm. At time points of t = 0, 1, 3, and 5 h, the
reaction was quenched with a final concentration of 1% TFA. Analysis
was performed on a 1290 Infinity coupled to a 6120 quadrupole LC/
MS (Agilent Technologies) using a Zorbax Eclipse XDB-C18
reversed-phase column (4.6 × 150 mm, particle size 5 μm, Agilent
Technologies) and a linear gradient of 10−60% B in 10 min (solvent
A: H2O + 0.1% TFA; solvent B: acetonitrile + 0.1% TFA; flow rate of
1 mL min−1). MS spectra were obtained with solvents containing
0.1% formic acid and 0.01% TFA. For K1 + Bz3, the gradient was
adjusted to 10−80% B in 10 min. For full conversion of protein, 50
μM K1 was incubated with 1 mM tris-electrophile (stock solution:
100 mM in DMSO) in cross-linking buffer (50 mM HEPES, pH 8.5,
50 mM NaCl) at 350 rpm. Depending on the tris-electrophile, the
incubation time and temperature were adjusted (for details, see Table
S1). A buffer exchange was performed using Vivaspin 500 centrifugal
concentrators (3 kDa MWCO, rt) before measurements.
Circular Dichroism Spectroscopy. All CD and thermal stability
measurements were performed with 2 μM protein in buffer (5 mM
sodium phosphate, pH 7.4, 20 °C) using a cuvette with 10 mm optical
path length. Measurements were performed on a Jasco J-1500 CD
spectrometer equipped with a Jasco CTU-100 temperature control
unit. CD spectra were recorded using the following settings: λ = 260−
195 nm, DIT = 2 s, bandwidth = 1 nm, scanning speed = 100 nm
min−1 (10 accumulations). Molar ellipticity at λ = 222 nm ([θ]222/deg









raw is ellipticity (mdeg) at λ = 222 nm, c is the molar
concentration of the protein (mol L−1), n is the number of amino
acids in the protein, and L is the path length of the cuvette (mm). The
helical content (or helicity/%) was determined using the so-called
“222 nm method”32 with the equation
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where [θ]222
0 = −3000 deg cm2 dmol−1 and [θ]222100 = −39 500 deg cm2
dmol−1 at λ = 222 nm and correspond to the estimated ellipticity for a
protein with 0 and 100% helical content, respectively. For thermal
stability measurements, the following settings were used: λ = 222 nm,
temperature range = 20−98 °C, heating rate = 1 °C min−1 (with 1 °C
increments), DIT = 2 s, bandwidth = 1 nm. Jasco spectra analysis
software (version 2.15.09) was used to determine the melting
temperature (Tm). Smoothing (convolution width = 21) and first
derivative calculations (convolution width = 11) were performed
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NMR spectra of tris-electrophiles, HPLC chromato-
grams of protein cross-linking reactions, and MS spectra,
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